117 related articles for article (PubMed ID: 3361352)
1. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
Sato M; Kaji R; Urata M; Yoshida H; Yanagawa T; Miyamoto K; Azuma M; Furumoto N; Saito M
J Biol Response Mod; 1988 Apr; 7(2):212-28. PubMed ID: 3361352
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
Kaji R; Yoshida H; Yanagawa T; Sato M
J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
[TBL] [Abstract][Full Text] [Related]
3. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432.
Okamoto M; Kaji R; Kasetani H; Yoshida H; Moriya Y; Saito M; Sato M
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):232-42. PubMed ID: 8334107
[TBL] [Abstract][Full Text] [Related]
5. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
[TBL] [Abstract][Full Text] [Related]
6. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
Ishida N; Saito M; Nanjo M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
[TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
Ujiie T
Jpn J Exp Med; 1988 Apr; 58(2):109-14. PubMed ID: 3261814
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
[TBL] [Abstract][Full Text] [Related]
9. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
[TBL] [Abstract][Full Text] [Related]
10. Augmentation by OK-432 of generation of culture-induced killer cells.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
Oshimi K; Kano S; Takaku F; Okumura K
J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
[TBL] [Abstract][Full Text] [Related]
12. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
Mizushima Y; Hirata H; Sakamoto K; Sato M; Morikage T; Maruyama M; Sasaki K; Yano S
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2710-5. PubMed ID: 3631971
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
[TBL] [Abstract][Full Text] [Related]
14. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
Yamaue H; Tanimura H; Iwahashi M; Tsunoda T; Tani M; Inoue M
Biotherapy; 1990; 2(1):51-61. PubMed ID: 2400628
[TBL] [Abstract][Full Text] [Related]
15. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.
Seaman WE; Sleisenger M; Eriksson E; Koo GC
J Immunol; 1987 Jun; 138(12):4539-44. PubMed ID: 3584981
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
[TBL] [Abstract][Full Text] [Related]
17. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
18. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
19. [Immunological competence of nude mice on the growth of transplantable human tumors--with reference to natural killer cells].
Konno H; Kubota T; Tsuyuki K; Nakada M; Kubouchi K; Yoshizumi Y; Asanuma F; Kurihara H; Koh J; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1983 Mar; 10(3):775-80. PubMed ID: 6881996
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]